Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Measles

Measles

Part of Human Metapneumovirus Infection

19 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Measles

29 trials tracked for Measles: 24 in phase 3 or 4 and 10 with published results. The most-cited published study has 38 citations.

29Trials tracked
24Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 4 3 Phase 3 21 Phase 2 5
  1. Phase 3 Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Completed · 38 cited
  2. Phase 3 Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) Completed · 30 cited
  3. Phase 3 Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM Completed · 19 cited
  4. Phase 3 Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age Completed · 18 cited
  5. Phase 3 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life Completed · 14 cited
  6. Phase 3 Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) Completed · 13 cited
Show 23 more trials
  1. Phase 3 Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children Completed · 10 cited
  2. Phase 3 ProQuad® Intramuscular vs Subcutaneous Completed · 10 cited
  3. Phase 3 Safety Study of ProQuad® rHA in Infants (V221-037) Completed · 9 cited
  4. Phase 4 Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Completed · 3 cited
  5. Phase 4 Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Completed
  6. Phase 4 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) Completed
  7. Phase 3 Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 Completed
  8. Phase 3 Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers Completed
  9. Phase 3 Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age Completed
  10. Phase 3 Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines Completed
  11. Phase 3 V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) Completed
  12. Phase 3 ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) Completed
  13. Phase 3 Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers Completed
  14. Phase 3 A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Completed
  15. Phase 3 Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers Completed
  16. Phase 3 A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) Completed
  17. Phase 3 Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) Completed
  18. Phase 3 Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) Completed
  19. Phase 2 A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age Completed
  20. Phase 2 ProQuad Dose Selection Study (V221-011)(COMPLETED) Completed
  21. Phase 2 Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age Completed
  22. Phase 2 Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds Completed
  23. Phase 2 Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age Completed

Showing the 29 most-cited and recently-updated of 29 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Suspected measles case reported in unvaccinated child in Clark County, Washington
Pediatrics
Suspected measles case reported in unvaccinated child in Clark County, Washington Health officials report suspected measles case in unvaccinated child in Washington
A case report describes a suspected measles case in an unvaccinated child recently arrived from Ukraine in Clark County, Washington.
A suspected measles case involving an unvaccinated child recently arrived from Ukraine has been reported in Clark County, Washington.
CDC Apr 4, 2026
PRIORIX vaccine recommended for measles, mumps, and rubella protection in the United States
Allergy & Immunology
PRIORIX vaccine recommended for measles, mumps, and rubella protection in the United States CDC panel recommends PRIORIX vaccine for measles, mumps, and rubella protection
A recommendation for the use of PRIORIX vaccination against measles, mumps, and rubella has been issued in the United States.
A CDC advisory panel now recommends the PRIORIX vaccine as a new option alongside the familiar MMR shot for measles, mumps, and rubella prot…
CDC Apr 4, 2026
Measles outbreak reported in New Mexico, details on population and interventions not provided
Infectious Disease
Measles outbreak reported in New Mexico, details on population and interventions not provided Health officials report a measles outbreak in New Mexico
An outbreak report describes a measles outbreak in New Mexico.
New Mexico health officials report a confirmed measles outbreak in 2025, urging residents to follow local guidance as the investigation cont…
CDC Apr 4, 2026
Measles outbreak in Colorado linked to exposure from an infectious international traveler
Infectious Disease
Measles outbreak in Colorado linked to exposure from an infectious international traveler How did Colorado respond to a measles outbreak from an international traveler?
An outbreak report describes a measles outbreak in Colorado among people exposed to an infectious traveler arriving on an international flig…
A single measles case from an international traveler in Colorado triggered a swift public health response to stop the virus from spreading f…
CDC Apr 4, 2026
Measles vaccine coverage increased in Eastern Mediterranean children but remains below elimination target
Pediatrics
Measles vaccine coverage increased in Eastern Mediterranean children but remains below elimination target Are we getting closer to eliminating measles in the Eastern Mediterranean?
An observational study of children in the Eastern Mediterranean Region from 2013-2018 found that the number receiving two measles vaccine do…
More children in the Eastern Mediterranean received two measles vaccine doses between 2013 and 2018, yet coverage still falls short of the 9…
CDC Apr 4, 2026
Measles outbreak reported among unvaccinated children in Illinois apartment complex
Pediatrics
Measles outbreak reported among unvaccinated children in Illinois apartment complex Measles outbreak reported among unvaccinated children in Illinois apartment complex
An outbreak investigation report describes a measles outbreak among unvaccinated, vaccine-eligible children at an apartment complex in Cook …
Unvaccinated children in an Illinois apartment complex are now facing a measles outbreak, proving that skipping shots leaves families vulner…
CDC Apr 4, 2026
Case report: Initial positive measles IgM tests in two Samoan children were false positives
Dermatology
Case report: Initial positive measles IgM tests in two Samoan children were false positives When a measles test says yes, could it really mean no?
An outbreak report describes two children in American Samoa with rash illness and initial positive measles IgM tests.
A positive measles test for two children in American Samoa turned out to be wrong, revealing other viruses can mimic the disease.
CDC Apr 2, 2026

Questions about Measles

What public health response was used for measles among Afghan evacuees in the US?

Public health officials in the US organized a mass vaccination campaign specifically for Afghan evacuees after measles cases were identified within that group.

Full answer →
Did measles cases increase in Galmudug State, Somalia between 2023 and 2024?

Yes, measles cases increased in Galmudug State, Somalia, rising from an incidence of 4.9 per 10,000 people in 2023 to 8.1 per 10,000 in 2024.

Full answer →